FDA Warning Letter: Marcus Research Laboratory, Inc.
type: Action
additional type: https://schema.org/RegulationAction
start time: 2021-10-19
description: CGMP/Active Pharmaceutical Ingredient (API)/Adulterated. Issued by FDA Division of Pharmaceutical Quality Operations III on 2021-09-30.
agent: FDA Division of Pharmaceutical Quality Operations III
object: Marcus Research Laboratory, Inc.
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
source organization: U.S. Food and Drug Administration
publisher: AI Analytics

PropertyValue
property ID: FDA Warning Letter ID
value: e328fa47b66871f9

AI Analytics
type: Organization